BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31776267)

  • 1. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
    Mohamed A; Smiley JR; Shmulevitz M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
    Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus -independent host genes, via mechanisms of slow replication versus polymorphisms in dsRNA binding σ3 respectively.
    Mohamed A; Konda P; Eaton HE; Gujar S; Smiley JR; Shmulevitz M
    PLoS Pathog; 2020 Sep; 16(9):e1008803. PubMed ID: 32956403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.
    Kawagishi T; Kanai Y; Nouda R; Fukui I; Nurdin JA; Matsuura Y; Kobayashi T
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells.
    Mohamed A; Teicher C; Haefliger S; Shmulevitz M
    J Virol; 2015 Apr; 89(8):4319-34. PubMed ID: 25653434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.
    Shmulevitz M; Gujar SA; Ahn DG; Mohamed A; Lee PW
    J Virol; 2012 Jul; 86(13):7403-13. PubMed ID: 22532697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of reovirus pathogenesis in a murine model of respiratory infection.
    Nygaard RM; Lahti L; Boehme KW; Ikizler M; Doyle JD; Dermody TS; Schiff LA
    J Virol; 2013 Aug; 87(16):9279-89. PubMed ID: 23760238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.
    Fernandes JP; Cristi F; Eaton HE; Chen P; Haeflinger S; Bernard I; Hitt MM; Shmulevitz M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Mismatches Caused by Reassortment Influence Functions of the Reovirus Capsid.
    Thete D; Danthi P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis.
    Dina Zita M; Phillips MB; Stuart JD; Kumarapeli AR; Snyder AJ; Paredes A; Sridharan V; Boerma M; Danthi P; Boehme KW
    J Virol; 2022 Jan; 96(2):e0187921. PubMed ID: 34757847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reovirus Core Proteins λ1 and σ2 Promote Stability of Disassembly Intermediates and Influence Early Replication Events.
    Gummersheimer SL; Danthi P
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing and complementation of reovirus core protein mu2: functional correlations with mu2-microtubule association and differences between virus- and plasmid-derived mu2.
    Carvalho J; Arnold MM; Nibert ML
    Virology; 2007 Aug; 364(2):301-16. PubMed ID: 17451769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of mammalian reoviruses for use as oncolytic agents.
    Van Den Wollenberg DJ; Van Den Hengel SK; Dautzenberg IJ; Kranenburg O; Hoeben RC
    Expert Opin Biol Ther; 2009 Dec; 9(12):1509-20. PubMed ID: 19916732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reovirus μ1 Protein Affects Infectivity by Altering Virus-Receptor Interactions.
    Thete D; Snyder AJ; Mainou BA; Danthi P
    J Virol; 2016 Dec; 90(23):10951-10962. PubMed ID: 27681135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.
    van den Wollenberg DJ; Dautzenberg IJ; van den Hengel SK; Cramer SJ; de Groot RJ; Hoeben RC
    PLoS One; 2012; 7(10):e48064. PubMed ID: 23110175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reovirus Neurotropism and Virulence Are Dictated by Sequences in the Head Domain of the Viral Attachment Protein.
    Sutherland DM; Aravamudhan P; Dietrich MH; Stehle T; Dermody TS
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reovirus mu2 protein determines strain-specific differences in the rate of viral inclusion formation in L929 cells.
    Mbisa JL; Becker MM; Zou S; Dermody TS; Brown EG
    Virology; 2000 Jun; 272(1):16-26. PubMed ID: 10873745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncanonical Cell Death Induction by Reassortant Reovirus.
    Rodríguez Stewart RM; Raghuram V; Berry JTL; Joshi GN; Mainou BA
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype-specific differences in inhibition of reovirus infectivity by human-milk glycans are determined by viral attachment protein σ1.
    Iskarpatyoti JA; Morse EA; McClung RP; Ikizler M; Wetzel JD; Contractor N; Dermody TS
    Virology; 2012 Nov; 433(2):489-97. PubMed ID: 22999096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.